Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mountain Valley MD HoldingsMVMDF +3.64% Cash Ratio is 1.27 as of Mar. 2026, which is 92% below its 10-year median of 16.44. The stock has 3 warning signs investors should review. Among 975 Drug Manufacturers companies, Mountain Valley MD Holdings ranks better than 68.92% on this metric.
Mountain Valley MD Holdings has a Cash Ratio of 1.27. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Mountain Valley MD Holdings's Cash Ratio or its related term are showing as below:
MVMDF'
s Cash Ratio Range Over the Past 10 Years
Min: 1.27 Med: 16.44 Max: 34.19
Current: 1.27
During the past 7 years, Mountain Valley MD Holdings's highest Cash Ratio was 34.19. The lowest was 1.27. And the median was 16.44.
MVMDF's Cash Ratio is ranked better than 68.92% of 975
companies
in the Drug Manufacturers industry
Industry Median: 0.61
vs MVMDF: 1.27
Mountain Valley MD Holdings (OTCPK:MVMDF) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Mountain Valley MD Holdings Cash Ratio Related Terms
Mountain Valley MD Holdings Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mountain Valley MD Holdings's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mountain Valley MD Holdings Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mountain Valley MD Holdings's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Mountain Valley MD Holdings's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mountain Valley MD Holdings (MVMDF) has a Cash Ratio of 1.27 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Mountain Valley MD Holdings and its competitors. This is 92% below median its historical median of 16.44. Over the past decade, Mountain Valley MD Holdings' Cash Ratio has ranged from 1.27 to 34.19. According to the industry distribution chart, Mountain Valley MD Holdings ranks #303 out of 975 companies in the Drug Manufacturers industry, placing it in the top 31.1%.
Is Mountain Valley MD Holdings' Cash Ratio too high?
Mountain Valley MD Holdings' current Cash Ratio of 1.27 is 92% below median its 10-year median of 16.44. Over the past 10 years, this metric has ranged from a low of 1.27 to a high of 34.19. The Drug Manufacturers industry median Cash Ratio is 0.61. Mountain Valley MD Holdings' value of 1.27 is 108.2% above this industry median. Based on the distribution chart, Mountain Valley MD Holdings ranks #303 out of 975 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Mountain Valley MD Holdings' Cash Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mountain Valley MD Holdings ranks #303 out of 975 companies for Cash Ratio. This puts Mountain Valley MD Holdings in the upper half of its industry. The industry median Cash Ratio is 0.61. Mountain Valley MD Holdings' value of 1.27 is 108.2% above this benchmark. Historically, Mountain Valley MD Holdings' own Cash Ratio has ranged from 1.27 to 34.19 over the past decade. While the company's 10-year median is 16.44 vs. the industry median of 0.61, Mountain Valley MD Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 975 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mountain Valley MD Holdings's current Cash Ratio of 1.27 is 108.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Mountain Valley MD Holdings and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mountain Valley MD Holdings's current Cash Ratio is 1.27, which is 92% below median its own 10-year median of 16.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mountain Valley MD Holdings stock overvalued right now?
Mountain Valley MD Holdings (MVMDF) has a current Cash Ratio of 1.27. The current Cash Ratio is 1.27, which is 92% below median its 10-year median of 16.44 and 108.2% above the Drug Manufacturers industry median of 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Mountain Valley MD Holdings (MVMDF), the current Cash Ratio is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Mountain Valley MD Holdings Inc is a Canada-based company. The firm, along with its subsidiaries, is engaged in implementing its Quicksome oral delivery technologies across a variety of molecules in nutraceutical, vaccine, and pharmaceutical drug applications. The company actively invests in and collaborates on pioneering biotechnologies that have the potential to revolutionize the human health and wellness landscape, drive sustainable increases in plant yields and agricultural farming practices, and broadly support animal husbandry health. The Company is a biotech company focused on advancing solutions to optimize human, animal, and plant health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MVMDF has been successfully added to your 
